Strong sides of clinic

Advantages of our clinic


Quality & Our strong sides

We do not deny that stem therapy is still referred to as experimental in world medicine, this is mainly due to the lack of a large number of clinical trials, primarily due to the high cost of biomaterial. But this is the only one potential direction of medicine, which gives real results in the treatment of serious diseases and conditions.

We guarantee our patients the purity of the product, safety of use, we guarantee the complete elimination of complications, side effects,  because  we control ourselves all processes from material sampling, cultivation, injections and controlling of the result.

Ukraine was one of the first countries in the world to start research with different types of stem cells since 1985 on science level.

In 1999 Ukrainian Parliament approved Law of Ukraine about the Transplantation of Organs and Other Anatomical Structures to Human that regulates the application of fetal ( umbilical and other types) stem cells in treatment of people in severe disease conditions. From those moment were conducted dozens of preclinical study and clinical trials on the efficacy of  stem cells transplantation .This Law reviews introduction of  stem cells into body as transplantation, and the cells themselves as graft.

1)We are the pioneers in the area of cell therapy using cryopreserved, tissue-specific stem/progenitor cells of origin; more than 37 years

2) We have the largest cell banks in Ukraine and have successfully send our bio materials for patients from all over the world including  Poland, Israel, USA, China, UAE, Turkey, Germany.. etc.; On legal collaboration we work with the biggest clinic: Charite Clinic ( Germany) , Israel Medical Centre Shiba, Clinic of Munich University, Mayo Clinic ( USA)

3)Stem cells banking legislation differs from country to country. For example in the USA umbilical cord blood banks` practice is strictly controlled by FDA (organization that is also involved in medicine and food control). FDA approved using some kinds of stem cell in treatment of some diseases!!! In addition, cord blood banks in New-York, New-Jersey and California require additional accreditation to practice legally. Biobank, that doesn`t have such an accreditation, has no right to function at all. In the EU cord blood banks are coordinated and controlled by international organization.  Net cord supported by European Parliament. Net cord both controls the activities of biobanks, and propagates umbilical cord blood banking among people. Ukrainian legislation requires umbilical cord blood banks to satisfy license conditions developed by The Ministry of Health Care of Ukraine. Subject to this satisfaction, the biobank is granted permission for licensed activities such as cells and tissue preservation.

4)All our technologies are patented and protected by copyrights. Our scientific results are published in national and international journals; Cell Biology and Translational Medicine, MDPI, Oxford press, World journal of Stem Cells, Life Science and others expert publications.

5) Our consultants are the leading experts of Ministry of Health and National Academy of Sciences of Ukraine. We partner with leading Ukrainian Research Institutes;

6) We are the member of the International Society for Cell Therapy (ISCT) , International Placenta Stem Cell Society (IPLASS), International Society for Stem Cell Research (ISSCR), International Federation of Placental Research Associations (IFPA)

7) The international quality management system ISO 9001:2015 constantly allows us to monitor and improve the quality of medical services and technological processes in order to meet maximally the needs of our patients. The leading international certification company TÜV Rheinland / LGA InterCert (Germany) conducted an audit for the compliance of our company

8) we are the company that combine: own  medical center 8000 m2, cryobank is located on more than a 1000 m² of a separated biotechnological complex, including its own clinical diagnostics laboratory, PCR laboratory, processing laboratories, research laboratory, quarantine and main cryopreservation laboratory/facility. In addition, the complex includes a round-the-clock logistics service and information support service, client department, as well as departments providing uninterrupted operation of the complex.

The biotechnological complex is equipped with modern equipment, has 24/7 multi-level protection and is capable of operating autonomously for a long time, due to the availability of autonomous systems of life support, generators and additional reserves of liquid nitrogen. Currently, the company employs more than 600 highly qualified staff and attracted specialists.


Multiple sclerosis

Stem cell treatment can  restore myelin, the sheath of nerve cells.  At the same time, the normal conduction of all nerve impulses returns, and the cells of the spinal cord and brain damaged by sclerosis are renewed.  The functioning of the immune system is regulated, which attacks the human nerve cells, provoking the development of the disease.  The uniqueness of regenerative therapy in the treatment of  MS differs from other applied therapeutic methods in that high results are achieved in treating the cause of the disease, and not symptomatic manifestations.

The main visible results of cell therapy are observed already 3-4 months after the stem cell transplantation.  Patients experience a surge of new strength and energy.  Cell therapy restores the normal reception and transmission of various nerve impulses to various tissues and organs of the human body.  Thanks to the correctly received and understood neuronal signal, muscle spasms are no longer observed, and the limbs completely get rid of tremors, weakness and numbness.  The patient’s movements regain confidence and clarity, motor skills and motor coordination are restored.  The patient begins to move independently, and his gait becomes more confident with each subsequent day.  As a result of cell therapy, the chronic fatigue that follows the patient is overcome, and numerous cognitive disorders disappear.  The ability for mental activity and normal concentration of attention returns.  The memory function is also restored.


The treating autism with mesenchymal stem cells derived from umbilical cord tissue mean that autism and its severity correlate with significantly with inflammatory and neuroinflammatory cytokines, including chemokine derived from macrophages (MDC) and thymus and activation-regulated chemokine (TARC). Numerous clinical trials have shown that intravenous  and lumbar administration of umbilical cord MSCs reduces inflammation. Reducing inflammation in an autistic patient can relieve autism symptoms.

Practice shows that at an early age for children, the effect of cell therapy is much better and the results are remarkable. The sooner you go for treatment , the better your chances of recovery. Since mild forms of the disease can be completely healed and return your child to a full and normal life.

You can expect: expanding vocabulary, improving behavior, reducing aggression and unreasonable emotionality, improving adaptation in society.


This therapy of stem cells expands stem cell reserves and trigger self-renewal processes in all the body’s organs and tissues. They also stimulate the body’s own dormant stem cells, which improves the functioning of the internal organs, boosts the immune system, and increases energy levels. The effects observed in our patients have shown genuine rejuvenation from inside!

Treatment is always prepared according  to the individual needs of each patient, we ensures the best results from our therapy.

  • higher energy level, exercise power and capacity to work;
  • elimination of all inflammatory, allergic and infectious process
  • improved mental capacity, quicker thinking, better memory;
  • subsiding of muscular, joint and back pain, and headaches;
  • normalized functioning of internal organs ( lungs, liver, pancreas, stomach ,intestines ..)
  • boosted immunity;
  • stabilized metabolism, hormone levels and blood pressure;
  • better sleep and the elimination of chronic fatigue;
  • improved libido and sexual functions.



Stem cells have the unique ability to change into any cell in the body, called differentiation. They can be administered intravenously and find damaged tissues around organs. When used in regards to pulmory diaseases patients, stem cells can repair damaged lung tissue to combat emphysema or chronic bronchitis. Stem cells have natural anti-inflammatory properties, which can clear airways for those with chronic bronchitis.


Completed studies have shown the ability to quantify the effects of stem cell therapy. According to a report done by the Lung Institute called Autologous Stem Cell Therapy and its Effects on PD, over 82% of patients that attempted stem cell treatment had noticeable improvements in their quality of life after their therapies. Many of these patients reported increased lung capacity and the ability to walk following transfusion. These reports have positioned stem cells as one of the best viable options for current patients with PD. While stem cell treatment has not shown the ability to cure PD, its ability to repair damaged tissue and relatively invasive nature makes it an attractive alternative to patients.

Our Specialized Doctors

All our doctors are highly specialized in regenerative therapy using stem cells. Many of them are engaged in parallel research and development activities to improve treatment success rates for all untreatable diseases. Many of the world’s treatment protocols are taken from the foundations of our own research.

  • Neurologist
  • Anti-age therapist
  • Gastroenterologist
  • Gynecologist and urologist
  • Ophthalmologist
  • Orthopedist traumatology
  • Dermatologist
  • Trichology specialist
  • Otolaryngologist
  • Endocrinologist

Taras Petriv

Neurologist, neuro surgeon

The main directions of research and practice: neurosurgery, stem cell therapy, tissue engineering, peripheral nerve surgery.

PhD in neurosurgery (“Effect of neural crest stem cells transplantation on peripheral nerve regeneration in experimental sciatic nerve injury”)

Author and co-author of 23 scientific publications, including 2 patents, 3 monographs (Neurosurgery, 2013; Scales in Neurosurgery, 2015; Standardization in Neurosurgery, 2019).

Member of the Ukrainian Association of Neurosurgeons, European and World Associations of Neurosurgical Societies.

Zhelnonozhskaya Julia

Gynecologist, mammologist, oncologist

Medical experience 18 years

Gynecologist, surgeon, health management specialist.

The leading areas of medical activity are conservative and operative gynecology, mammology, minimally invasive surgery, and proctology.

He is fluent in and improves daily the modern skills of operational and conservative methods of treatment of various gynecological and surgical pathologies. Performs more than 450 surgical interventions per year.

He is a co-author of two patents for innovative methods of treatment in gynecology

He is an active participant in medical conferences and congresses with international participation. Repeatedly participated in foreign conferences, including as a speaker, as well as with poster presentations (Paris, Berlin).

He is a member of the associations of herniologists and obstetricians and gynecologists of Ukraine.

Is the best obstetrician-gynecologist according to the Doc.Ua patient record site


Mendel Mikolay

Gastroenterologist, surgeon

Membership in associations, societies; attending conferences, courses of thematic improvement

Member of the European Association of Endoscopic Surgery (EAES)

Member of the Ukrainian Association of Specialists in Minimally Invasive, Endoscopic and Laser Technologies (UAMELT)

Member of the European Hernia Society (EHS)


Candidate of Medical Sciences, Associate Professor, author of more than 250 scientific papers

Teaching activity and / or lecture activity


Olga Shishkina

Anti-age specialist, cardiology, therapist

Leading specialist of the clinic. Scientific degree – Doctor of Medical Sciences.

Achievements: co-authorship of 76 scientific publications; diploma of the Parliament of Ukraine; Order of Princess Olga 13 degrees; Title Honored Doctor of Ukraine.

From 2008 to the present day, Olga is the head of the therapeutic department of the SAD of the President of Ukraine.

Olga takes part in international conferences, symposia and seminars.